Literature DB >> 30325071

Tie-ing Up Angiogenesis to Treat Nonalcoholic Steatohepatitis.

Nicholas O Davidson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30325071      PMCID： PMC6393173          DOI： 10.1002/hep.30318

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  10 in total

1.  Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models.

Authors:  Stephanie Coulon; Vanessa Legry; Femke Heindryckx; Christophe Van Steenkiste; Christophe Casteleyn; Kim Olievier; Louis Libbrecht; Peter Carmeliet; Bart Jonckx; Jean-Marie Stassen; Hans Van Vlierberghe; Isabelle Leclercq; Isabelle Colle; Anja Geerts
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425

Review 2.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

3.  Neovascularization and oxidative stress in the progression of non-alcoholic steatohepatitis.

Authors:  Mitsuteru Kitade; Hitoshi Yoshiji; Hideyuki Kojima; Yasuhide Ikenaka; Ryuichi Noguchi; Kosuke Kaji; Junichi Yoshii; Koji Yanase; Tadashi Namisaki; Masaharu Yamazaki; Tatsuhiro Tsujimoto; Kei Moriya; Hideto Kawaratani; Takemi Akahane; Hiroshi Fukui
Journal:  Mol Med Rep       Date:  2008 Jul-Aug       Impact factor: 2.952

4.  Tie1: an orphan receptor provides context for angiopoietin-2/Tie2 signaling.

Authors:  Sarah B Mueller; Christopher D Kontos
Journal:  J Clin Invest       Date:  2016-08-22       Impact factor: 14.808

5.  Angiopoietin-2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease.

Authors:  Sander Lefere; Frederique Van de Velde; Anne Hoorens; Sarah Raevens; Sanne Van Campenhout; Astrid Vandierendonck; Sara Neyt; Bert Vandeghinste; Christian Vanhove; Charlotte Debbaut; Xavier Verhelst; Jo Van Dorpe; Christophe Van Steenkiste; Christophe Casteleyn; Bruno Lapauw; Hans Van Vlierberghe; Anja Geerts; Lindsey Devisscher
Journal:  Hepatology       Date:  2019-02-12       Impact factor: 17.425

6.  Characterization of non-alcoholic steatohepatitis-derived hepatocellular carcinoma as a human stratification model in mice.

Authors:  Kazuki Takakura; Shigeo Koido; Masato Fujii; Taishi Hashiguchi; Yuichiro Shibazaki; Hiroyuki Yoneyama; Hiroaki Katagi; Mikio Kajihara; Takeyuki Misawa; Sadamu Homma; Toshifumi Ohkusa; Hisao Tajiri
Journal:  Anticancer Res       Date:  2014-09       Impact factor: 2.480

7.  Tie1 controls angiopoietin function in vascular remodeling and inflammation.

Authors:  Emilia A Korhonen; Anita Lampinen; Hemant Giri; Andrey Anisimov; Minah Kim; Breanna Allen; Shentong Fang; Gabriela D'Amico; Tuomas J Sipilä; Marja Lohela; Tomas Strandin; Antti Vaheri; Seppo Ylä-Herttuala; Gou Young Koh; Donald M McDonald; Kari Alitalo; Pipsa Saharinen
Journal:  J Clin Invest       Date:  2016-08-22       Impact factor: 14.808

8.  Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation.

Authors:  Minah Kim; Breanna Allen; Emilia A Korhonen; Maximilian Nitschké; Hee Won Yang; Peter Baluk; Pipsa Saharinen; Kari Alitalo; Christopher Daly; Gavin Thurston; Donald M McDonald
Journal:  J Clin Invest       Date:  2016-08-22       Impact factor: 14.808

9.  Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Authors:  Ghassan K Abou-Alfa; Jean-Frederic Blanc; Steven Miles; Tom Ganten; Jörg Trojan; Jonathan Cebon; Andre K Liem; Lara Lipton; Charu Gupta; Benjamin Wu; Michael Bass; Ellen Hollywood; Jennifer Ma; Margaret Bradley; Jason Litten; Leonard B Saltz
Journal:  Oncologist       Date:  2017-06-07

Review 10.  Angiogenesis and Fibrogenesis in Chronic Liver Diseases.

Authors:  Claudia Bocca; Erica Novo; Antonella Miglietta; Maurizio Parola
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-07-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.